Americas (WHO region) vs Kazakhstan: Confirmed cases of RR-/MDR-TB
Americas (WHO region)
6,242
in 2024
Kazakhstan
3,413
in 2024
Americas (WHO region) rank
11th
Kazakhstan rank
11th
Confirmed cases of RR-/MDR-TB over time
- Americas (WHO region)
- Kazakhstan
How they compare
Americas (WHO region) currently reports 6,242 against 3,413 in Kazakhstan, a difference of 2,829.
That makes Americas (WHO region)'s figure about 1.8 times Kazakhstan's.
The two have swapped places 3 times across 19 shared years of data; in 2006 it was Kazakhstan ahead.
Americas (WHO region) ranks 11th and Kazakhstan ranks 11th of 11 groups.
Across the 3 decades both report, Americas (WHO region) averaged higher in 1 and Kazakhstan in 2.
Head to head by decade
| Decade | Americas (WHO region) | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2,986 | 4,322 | 1,336 | Kazakhstan |
| 2010s | 3,942 | 6,321 | 2,378 | Kazakhstan |
| 2020s | 5,414 | 3,608 | 1,806 | Americas (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of rr-/mdr-tb, Americas (WHO region) or Kazakhstan?
- Americas (WHO region), at 6,242 against 3,413 in Kazakhstan as of 2024.
- What is the difference in confirmed cases of rr-/mdr-tb between Americas (WHO region) and Kazakhstan?
- 2,829, with Americas (WHO region) ahead.
- How many years of comparable data are there for Americas (WHO region) and Kazakhstan?
- 19 years are reported by both, from 2006 to 2024.
- How do Americas (WHO region) and Kazakhstan rank globally for confirmed cases of rr-/mdr-tb?
- Americas (WHO region) ranks 11th and Kazakhstan ranks 11th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of RR-/MDR-TB. Statizoid refreshes it automatically from the source and publishes the full history for both places.